|Bid||0.110 x 0|
|Ask||0.115 x 0|
|Day's range||0.1100 - 0.1150|
|52-week range||0.0670 - 0.1900|
|Beta (3Y monthly)||3.53|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Botanix Pharmaceuticals Limited (ASX:BOT) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the Read More...
Cannabis-related research and development is booming at the moment as companies rush to capitalise on its gradual legalisation.
A look at the shareholders of Botanix Pharmaceuticals Limited (ASX:BOT) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies while huge Read More...
Today I will examine Botanix Pharmaceuticals Limited’s (ASX:BOT) latest earnings update (31 December 2017) and compare these figures against its performance over the past couple of years, in addition toRead More...